Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001386481 | SCV001586717 | pathogenic | not provided | 2020-09-25 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp499*) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with inherited retinal dystrophy (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 438087). Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001386481 | SCV004036751 | pathogenic | not provided | 2023-03-24 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32581362, 28041643) |
NIHR Bioresource Rare Diseases, |
RCV000504841 | SCV000598933 | likely pathogenic | Retinal dystrophy | 2015-01-01 | no assertion criteria provided | research | |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000505559 | SCV000599873 | pathogenic | Cone-rod dystrophy 3 | 2017-04-20 | no assertion criteria provided | clinical testing |